NLRP3 and type 2 diabetes mellitus: Emerging evidence has indicated that the activation of the NLRP3 inflammasome might lead to the maturation and secretion of IL-1β, which has been implicated in the pathological development of type 2 diabetes and cardiovascular diseases [29].